Caspase-3 has been found to cleave excitatory amino-acid transporter-2 (EAAT2) at a specific cytosolic c-terminal site resulting in the selective inhibition of this transporter hence playing a crucial role in the pathogenesis of ALS [19]. Here, CASP3 is linked to amyotrophic lateral sclerosis.